• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter by Pirera et al regarding the paper "Direct oral anticoagulants in embolic stroke of undetermined source: an updated meta-analysis" by Marinheiro and colleagues.

作者信息

Pirera Edoardo, D'Anna Lucio, Di Raimondo Domenico, Tuttolomondo Antonino

机构信息

Internal Medicine and Stroke Care ward, Department of Promoting Health, Maternal-Infant. Excellence and Internal and Specialized Medicine (Promise) G. D'Alessandro, University of Palermo, Palermo, Italy.

Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.

出版信息

J Thromb Thrombolysis. 2025 Feb;58(2):351-352. doi: 10.1007/s11239-024-03063-1. Epub 2024 Dec 4.

DOI:10.1007/s11239-024-03063-1
PMID:39633220
Abstract
摘要

相似文献

1
Letter by Pirera et al regarding the paper "Direct oral anticoagulants in embolic stroke of undetermined source: an updated meta-analysis" by Marinheiro and colleagues.
J Thromb Thrombolysis. 2025 Feb;58(2):351-352. doi: 10.1007/s11239-024-03063-1. Epub 2024 Dec 4.
2
In reply: letter to the editor about "Direct oral anticoagulants in embolic stroke of undetermined source: an updated meta-analysis".回复：致编辑的信，关于“不明来源栓塞性卒中的直接口服抗凝剂：一项更新的荟萃分析”
J Thromb Thrombolysis. 2025 Mar;58(3):481-483. doi: 10.1007/s11239-025-03080-8. Epub 2025 Apr 1.
3
Incidence of atrial fibrillation among patients with an embolic stroke of undetermined source: Insights from insertable cardiac monitors.不明来源栓塞性卒中患者中心房颤动的发生率：植入式心脏监测仪的相关研究。
Int J Stroke. 2019 Feb;14(2):146-153. doi: 10.1177/1747493018798554. Epub 2018 Sep 10.
4
Direct oral anticoagulants in embolic stroke of undetermined source: an updated meta-analysis.直接口服抗凝剂用于不明来源栓塞性卒中：一项更新的荟萃分析。
J Thromb Thrombolysis. 2024 Oct;57(7):1163-1171. doi: 10.1007/s11239-024-03017-7. Epub 2024 Jul 29.
5
Direct Oral Anticoagulants Versus Aspirin for Stroke Prevention After Embolic Stroke of Undetermined Source: An Updated Meta-Analysis of Randomized Controlled Trials.
J Clin Med. 2024 Nov 8;13(22):6730. doi: 10.3390/jcm13226730.
6
Importance of Finding Embolic Sources for Patients with Embolic Stroke of Undetermined Source.为不明来源栓塞性卒中患者寻找栓塞源的重要性。
J Stroke Cerebrovasc Dis. 2019 Jul;28(7):1810-1815. doi: 10.1016/j.jstrokecerebrovasdis.2019.04.022. Epub 2019 May 14.
7
Direct oral anticoagulants compared to aspirin for embolic stroke of undetermined source: A comprehensive meta-analysis.直接口服抗凝剂与阿司匹林治疗不明来源栓塞性卒中的比较：一项综合荟萃分析。
J Stroke Cerebrovasc Dis. 2025 Apr;34(4):108256. doi: 10.1016/j.jstrokecerebrovasdis.2025.108256. Epub 2025 Feb 6.
8
Frequency and features of embolic stroke of undetermined source in young adults.青年不明来源栓塞性卒中的发病率及特征
Eur Stroke J. 2018 Jun;3(2):110-116. doi: 10.1177/2396987318755585. Epub 2018 Jan 24.
9
Overview and Future Direction of Embolic Stroke of Undetermined Source from the Insights of CHALLENGE ESUS/CS Registry.不明来源栓塞性卒中的概述和未来方向：来自 CHALLENGE ESUS/CS 登记研究的见解。
J Atheroscler Thromb. 2024 Dec 1;31(12):1641-1651. doi: 10.5551/jat.RV22026. Epub 2024 Sep 27.
10
Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.卵圆孔未闭伴不明来源栓塞性卒中患者应用达比加群或阿司匹林治疗：RE-SPECT ESUS 研究结果。
Stroke. 2021 Mar;52(3):1065-1068. doi: 10.1161/STROKEAHA.120.031237. Epub 2021 Jan 28.

引用本文的文献

1
In reply: letter to the editor about "Direct oral anticoagulants in embolic stroke of undetermined source: an updated meta-analysis".回复：致编辑的信，关于“不明来源栓塞性卒中的直接口服抗凝剂：一项更新的荟萃分析”
J Thromb Thrombolysis. 2025 Mar;58(3):481-483. doi: 10.1007/s11239-025-03080-8. Epub 2025 Apr 1.

本文引用的文献

1
Direct oral anticoagulants in embolic stroke of undetermined source: an updated meta-analysis.直接口服抗凝剂用于不明来源栓塞性卒中：一项更新的荟萃分析。
J Thromb Thrombolysis. 2024 Oct;57(7):1163-1171. doi: 10.1007/s11239-024-03017-7. Epub 2024 Jul 29.
2
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial.阿哌沙班预防心房心肌病所致隐源性卒中后复发的疗效：ARCADIA 随机临床试验。
JAMA. 2024 Feb 20;331(7):573-581. doi: 10.1001/jama.2023.27188.
3
Apixaban versus Aspirin for Embolic Stroke of Undetermined Source.
阿哌沙班与阿司匹林用于不明来源栓塞性脑卒中的比较。
NEJM Evid. 2024 Jan;3(1):EVIDoa2300235. doi: 10.1056/EVIDoa2300235. Epub 2023 Dec 22.
4
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.达比加群酯预防来源不明的栓塞性卒中后卒中
N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.
5
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.利伐沙班预防来源不明的栓塞性卒中后卒中
N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16.